Umkalor (Umckalor®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbsporal solution
Composition:

100 g of solution contains:

Active components:

pelargonium sidovid root extract liquid EPs 7630 (1: 8-10) - 80 g, extractant - ethanol 11% (w / w)

Auxiliary components:

Glycerol 85% - 20 g

Description:

Transparent or slightly opalescent liquid from light brown to reddish brown.

Pharmacotherapeutic group:antimicrobial agent of plant origin
ATX: & nbsp
  • Other combined drugs used for catarrhal diseases
    • Pharmacodynamics:

    Has antimicrobial effect, has mucolytic properties, contributes to increase of nonspecific resistance of the organism.

    Pharmacokinetics:

    Pelargonium sidovid root extract liquid contains a large amount biologically active substances, which together determine its pharmacological activity. Therefore, the data on the pharmacokinetics of individual chemical components that make up the extract are not sufficient for extrapolation to the preparation as a whole.

    Indications:

    Acute and chronic infectious and inflammatory diseases of the respiratory tract and ENT organs (sinusitis, rhinopharyngitis, tonsillitis, bronchitis) as part of complex therapy.

    Contraindications:

    Hypersensitivity to the components of the drug, predisposition to bleeding, severe hepatic and renal insufficiency, children under 1 year of age (due to the presence of ethyl alcohol in the preparation), simultaneous use of anticoagulants.

    Carefully:

    Alcoholism, craniocerebral trauma, brain disease, impaired liver and kidney function (no experience of use), children's age from 1 year.

    Pregnancy and lactation:

    Due to the lack of sufficient clinical data, the use of the drug during pregnancy and breastfeeding is not recommended.

    Dosing and Administration:

    Adults and children over 12 years of age it is recommended to take 20-30 drops 3 times a day;

    children aged 6 to 12 years - 10-20 drops 3 times a day;

    children from 1 year to 6 years - 5-10 drops 3 times a day.

    The drug should be taken 30 minutes before meals with a small amount of liquid.

    When dosing the drug, hold the bottle upright, if necessary, tapping slightly on the bottom of the bottle.

    After the disappearance of the symptoms of the disease is recommended to continue treatment for several days to prevent relapse.

    The average duration of treatment is 10 days.

    Side effects:

    Estimating the incidence of adverse reactions is based on the WHO classification:

    Very frequent - 1/10 appointments (≥ 10%),

    Frequent - 1/100 appointments (≥1%, but <10%),

    Infrequent - 1/1000 appointments (≥ 0,1%, but <1%),

    Rare - 1/10000 appointments (≥ 0.01%, but <0.1%),

    Very rare - less than 1 / 10,000 appointments (0.01%).

    Disorders from the immune system, skin and subcutaneous tissue

    Rarely, allergic reactions may occur.

    Respiratory, thoracic and mediastinal disorders

    Rarely minor nasal bleeding is rare.

    Gastrointestinal disorders

    It is not often possible complaints from the gastrointestinal tract (such as nausea, vomiting, epigastric pain or diarrhea); rarely - slight bleeding gums.

    Hepatobiliary disorders

    There may be signs of liver dysfunction (such as yellowing of the skin, yellowing of the eye proteins). The causal relationship of this manifestation with the use of the drug is not confirmed, the frequency of occurrence is unknown.

    Overdose:

    No cases of drug overdose have been reported to date.

    The drug is well tolerated.

    Interaction:

    When used simultaneously with anticoagulants, including coumarin derivatives, it is possible to increase their anticoagulant effect and bleeding (bleeding from the nose, bleeding gums).

    Special instructions:

    During storage, liquid plant extracts tend to cloud, but this does not affect their pharmacological efficacy. Since Umkalor is a natural product, slight changes in the color and taste of the preparation are possible.

    In connection with the ethanol content of 12% (v / v) in the preparation, it should be taken into account that the maximum single dose for children over 12 years and adults contains 0.125 grams of absolute ethyl alcohol, the maximum daily dose for children over 12 years and adults contains 0.375 grams of absolute ethyl alcohol. A single dose for children under 12 years of age contains less than 0.1 g of absolute ethyl alcohol.

    In the absence of a therapeutic effect on the background of taking the drug for 7 days, while maintaining a high temperature for several days, the appearance of dyspnea or bloody sputum, the appearance of signs of liver dysfunction (such as yellowing of the skin,yellowing of the eyes), it is necessary to consult a doctor.

    Effect on the ability to drive transp. cf. and fur:

    When using the drug should be careful when dealing with potentially dangerous activities that require increased concentration and speed of psychomotor reactions (including driving, working with moving mechanisms).

    Form release / dosage:Solution for ingestion.
    Packaging:

    For 20 ml and 50 ml in a bottle of dark glass of hydrolytic class III, equipped with a dropper of low-density polyethylene and a screw cap made of polypropylene.

    Each bottle together with instructions for use is placed in a cardboard pack.

    Storage conditions:

    Store at a temperature not exceeding 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    2 years.

    Do not use after the expiry date printed on the package.

    After opening the vial, it should not be stored for more than 6 months.

    Terms of leave from pharmacies:Without recipe
    Registration number:П N010150
    Date of registration:01.09.2011 / 17.03.2014
    The owner of the registration certificate:Dr. Wilmar Schwabe GmbH & Co. KGDr. Wilmar Schwabe GmbH & Co. KG Germany
    Manufacturer: & nbsp
    Representation: & nbspDr. Wilmar Schwabe GmbH & Co. KG. KG Dr. Wilmar Schwabe GmbH & Co. KG. KG Germany
    Information update date: & nbsp07.03.2016
    Illustrated instructions
      Instructions
      Up